comparemela.com
Home
Live Updates
Mike Bassett - Breaking News
Pages:
11
12
13
14
15
16
17
Latest Breaking News On - Mike bassett - Page 10 : comparemela.com
Novel PARP1 Inhibitor Shows Promise in Breast Cancer
The drug had favorable safety compared with first-generation PARP inhibitors in phase I/II study
United states
New haven
Mike bassett
Timothy yap
Patricia lorusso
American association for cancer research
Yale school of medicine
University of texas md anderson cancer center
Cancer center
American association
Cancer research
Yale school
Most Cancer Drugs Granted Accelerated Approval Fail Confirmatory Trials
Only 43% showed clinical benefit within 5 years
United states
Edward scheffer cliff
Shivaani kummar
Mike bassett
American association for cancer research
Oregon health science university in portland
Harvard medical school
American association
Cancer research
Oregon health
Science university
Can Late-Stage Cancer Incidence Serve as an Endpoint for Screening Trials?
Study shows it may be an alternative to cancer-specific mortality for some cancers, but not all
United states
Peterb bach
Mike bassett
Hilarya robbins
American association for cancer research
International agency
American association
Cancer research
North america
PSA and Biomarker Testing Plus MRI Appears to Improve Prostate Cancer Screening
Early results suggest approach reduces overdiagnosis while better detecting high-grade cancer
United states
Vanderbilt university
Mike bassett
Anssi auvinen
Jeffreyj tosoian
Tampere university
Vanderbilt university medical center
Finnish proscreen
European randomized study
Prostate cancer
More Bird Flu Spread; FDA to Allow Gay Men to Donate Sperm; Oatzempic Trend
Health news and commentary from around the Web gathered by <em>MedPage Today</em> staff
United states
New york
United kingdom
New mexico
Jerome adams
Kristin lyerly
Mike bassett
Bristol myers squibb
Washington post
New york times
World organisation for animal health
Health news
World organisation
Animal health
Wall street journal
Daily mail
vimarsana © 2020. All Rights Reserved.